文献速递鼻科

新型冠状病毒感染相关嗅觉倒错的临床特征

Clinical Features of Parosmia Associated With COVID-19 Infection.
PubMed 文献 · Laryngoscope · 2021-12-13

研究纳入2020年8月至2021年3月耳鼻咽喉科和初级保健机构的COVID-19相关嗅觉障碍患者,231名受访者中148名(64.1%)报告嗅觉倒错。嗅觉倒错者嗅觉识别测试得分更高(8.7 vs 7.5,P=0.006),但生活质量评分更差;嗅觉倒错者更年轻(40.2 vs 44.9岁,P=0.007),慢性鼻窦炎病史比例更低(7.2% vs 0.7%,P=0.006)。

要点

  • COVID-19相关嗅觉障碍患者中64.1%报告嗅觉倒错。
  • 嗅觉倒错者嗅觉识别得分更高但生活质量更差。
  • 嗅觉倒错者更年轻且慢性鼻窦炎病史更少。

核心结论

  • COVID-19相关嗅觉障碍常伴随嗅觉倒错,嗅觉倒错可在嗅觉丧失时或延迟出现,尽管定量嗅觉评分更好,但生活质量下降,多数持续性嗅觉倒错受访者已寻求治疗。

研究设计与样本

  • 从耳鼻咽喉科和初级保健机构招募2020年8月至2021年3月期间实验室确诊或临床疑似COVID-19相关嗅觉障碍个体,完成嗅觉障碍和生活质量问卷调查,共231名受访者。

主要发现

  • 231名受访者中148名(64.1%)报告嗅觉倒错。
  • 25.4%的受访者在任何COVID-19症状出现1周内发生嗅觉倒错,43.4%在症状出现超过1个月后发生。
  • 嗅觉倒错者简易嗅觉识别测试得分显著更高(8.7 vs 7.5,P=0.006)。
  • 嗅觉倒错者改良简版嗅觉障碍问卷阴性陈述评分更差(12.1 vs 8.5,P<0.001),鼻窦炎结局测试22评分更差(26.2 vs 23.2,P=0.113)。
  • 嗅觉倒错者更年轻(40.2 vs 44.9岁,P=0.007),慢性鼻窦炎病史比例更低(7.2% vs 0.7%,P=0.006)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize the clinical features, risk factors, symptom time-course, and quality of life implications for parosmia among coronavirus disease (COVID)-related olfactory dysfunction patients. METHODS: Individuals with olfactory dysfunction associated with laboratory-confirmed or clinically suspected COVID-19 infection were recruited from otolaryngology and primary care practices over a period from August 2020 to March 2021. Participants completed olfactory dysfunction and quality of life surveys. RESULTS: A total of 148 (64.1%) of 231 respondents reported parosmia at some point. Parosmia developed within 1 week of any COVID-19 symptom onset in 25.4% of respondents, but more than 1 month after symptom onset in 43.4% of respondents. Parosmia was associated with significantly better quantitative olfactory scores on Brief Smell Identification Test (8.7 vs. 7.5, P = .006), but demonstrated worse quality of life scores, including modified brief Questionnaire of Olfactory Dysfunction-Negative Statements and Sino-Nasal Outcome Test-22 scores (12.1 vs. 8.5, P < .001; 26.2 vs. 23.2, P = .113). Participants who developed parosmia at any point were significantly younger and less likely to have history of chronic sinusitis than those who did not develop parosmia (40.2 vs. 44.9 years, P = .007; 7.2% vs. 0.7%, P = .006). CONCLUSION: COVID-19-associated olfactory dysfunction is frequently linked with development of parosmia, which often presents either at onset of smell loss or in a delayed fashion. Despite better quantitative olfactory scores, respondents with parosmia report decreased quality of life. A majority of respondents with persistent parosmia have sought treatment. LEVEL OF EVIDENCE: 3 Laryngoscope, 132:633-639, 2022.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Lerner DK, Garvey KL, Arrighi-Allisan AE, et al. Clinical Features of Parosmia Associated With COVID-19 Infection. Laryngoscope. 2021. PMID: 34870334. doi:10.1002/lary.29982

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。